{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:44:11Z","timestamp":1771659851884,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":3104,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1111\/j.1469-0691.2006.01458.x","type":"journal-article","created":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T11:57:51Z","timestamp":1147435071000},"page":"555-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals"],"prefix":"10.1016","volume":"12","author":[{"given":"C.","family":"Tornero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Alberola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tamarit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01458.x_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV\u20101 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/CDLI.5.6.755-761.1998","article-title":"Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures","volume":"5","author":"Aziz","year":"1998","journal-title":"Clin Diagn Laboratory Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/CDLI.7.4.540-548.2000","article-title":"Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation","volume":"7","author":"Fahey","year":"2000","journal-title":"Clin Diagn Laboratory Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00126334-200405010-00006","article-title":"High plasma level of interleukin\u201018 in HIV\u2010infected subjects with lipodystrophy","volume":"36","author":"Lindegaard","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jmv.10434","article-title":"Production of interleukin\u201018 and interleukin\u201012 in patients suffering from chronic hepatitis C virus infection before antiviral therapy","volume":"70","author":"Schvoerer","year":"2003","journal-title":"J Med Virol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning a new cytokine that induces IFN\u2010\u03b3 production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.159.1.298","article-title":"Production of IL\u201018 (IFN\u2010\u03b3 inducing factor) messenger RNA and functional protein by murine keratinocytes","volume":"159","author":"Stoll","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin\u201018 regulates both th1 and th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib10","doi-asserted-by":"crossref","first-page":"12550","DOI":"10.1073\/pnas.95.21.12550","article-title":"Interleukin\u201018 stimulates HIV\u20101 replication in monocytic cells","volume":"95","author":"Shapiro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib11","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1128\/JVI.76.24.12448-12456.2002","article-title":"Elevated levels of circulating interleukin\u201018 in human immunodeficiency virus\u2010infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis","volume":"76","author":"Ahmad","year":"2002","journal-title":"J Virol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib12","first-page":"79","article-title":"Increased serum concentrations of soluble tumor necrosis factor receptors in HIV infected individuals are associated with immune activation","volume":"7","author":"Zangerle","year":"1994","journal-title":"J Acquired Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/173.2.464","article-title":"Soluble tumor necrosis factor\u2010alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV\u2010infected patients","volume":"173","author":"Bilello","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/514108","volume":"176","author":"Stein","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib15","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/00002030-200009290-00023","article-title":"Circulating levels of IL\u201018 in adult and paediatric patients with HIV\u20101 infection","volume":"14","author":"Torre","year":"2000","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/clim.2001.5033","article-title":"Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination anti\u2010retroviral therapy","volume":"99","author":"Saves","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1014475618504","article-title":"Correlations of soluble interleukin\u20102 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART","volume":"22","author":"Bonnet","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2249.2003.02179.x","article-title":"Raised serum levels of interleukin\u201018 is associated with disease progression and may contribute to virological treatment failure in HIV\u20101\u2010infected patients","volume":"132","author":"Stylianou","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.micinf.2004.07.009","article-title":"Plasma interleukin\u201018 is associated with viral load and disease progression in HIV\u20101\u2010infected patients","volume":"6","author":"Wiercinska\u2010Drapalo","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.1999.01083.x","article-title":"Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection","volume":"94","author":"Itoh","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib21","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/315052","article-title":"Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection","volume":"180","author":"Weiss","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2002.01911.x","article-title":"Interferon\u2010alpha induces interleukin\u201018 binding protein in chronic hepatitis C patients","volume":"129","author":"Kaser","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1469-0691.2006.01458.x_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0300-9475.2005.01529.x","article-title":"Interleukin (IL)\u20104, IL\u201010, IL\u201018 and IFN\u2010gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections","volume":"61","author":"El\u2010Kady","year":"2005","journal-title":"Scand J Immunol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14628524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14628524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:16:58Z","timestamp":1761117418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14628524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1198743X14628524"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01458.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01458.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}